2002
Small, Physiologic-shaped CONTAK CD 2 System Combines Treatment for Both Heart Failure and Sudden Cardiac Death Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a...
Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, will conduct a live webcast of its third quarter 2002 earnings...
NEUROLINK Stent May Provide Hope for Patients at High Risk for Recurrent Stroke Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment...
Conference Call/Webcast Scheduled at 11AM EDT Today Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT) reported that the United States District Court for the Northern District of...
World''s smallest, thinnest defibrillator offers advanced rhythm discrimination and industry-leading longevity Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a...
High-Performance, Low-Profile System Offers Physicians New Option Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac...
Early Data from 1,533-Patient Trial Supports Safety of Paclitaxel Eluting Stents In High-Risk Patients Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment...
Vulnerable Plaque Presents Significant Opportunity for Preventive Therapy Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular...
New Guideline Reflects Results of MADIT II Trial Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease,...
System Designed to Enable Physicians to Treat Long Vessel Blockages With Ease and Precision Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in...
Session to Improve Knowledge and Practices to Help Overcome Rising Mortality Rate Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and...
New Technology May Reduce Risk of Major Complications Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular...
Guidant Expands Agreement with Novartis Pharma AG Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, announced today...
Company Reiterates Guidance for 2002; Previews 2003 Full-Year Revenue and Earnings Per Share New York - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and...
Sixth-Generation MULTI-LINK Stent System Features Enhanced Deliverability, Market-Leading Stent Design Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world...
Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, announced today that it will conduct a live webcast of its annual...
Vulnerable Plaque Presents Significant Opportunity for Preventive Treatment Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular...
Approval Affirms Momentum of Breakthrough Therapy Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiac and vascular technology, today announced that the...
Company Raises Third Quarter 2002 Sales and Earnings Per Share Guidance Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular...
New System Enhances Physician''s Ability to Navigate Challenging Anatomy Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...
Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will host a...
Online tool provides latest information about treatment options for common condition DALLAS - The American Heart Association today announced a strategic relationship with Guidant Corporation, a...
CADILLAC Trial Was Largest Interventional Trial Evaluating Heart Attack Patients Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...
Additional Stent Lengths and Diameters Give Physicians Broader Treatment Options Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...
Results Show Efficacy in Patients Presenting with Abrupt or Threatened Abrupt Closure Indianapolis, Ind. and Santa Clara, Calif - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...